NCT02006589 - Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 11, 2013

Primary Completion Date

January 22, 2014

Study Completion Date

January 22, 2014

Conditions

Hypertension

Interventions

DRUG

Candesartan cilexetil (GW615775, Test formulation)

Test formulation candesartan cilexetil 8 mg will be supplied as round, biconvex pink tablets with PX 8 embossed in one face.

DRUG

Candesartan cilexetil (Reference treatment)

Reference treatment of candesartan cilexetil 8 mg will be supplied as round, biconvex pink tablets, scored in one face and with embossment in both faces (008 embossment in the plain face and A CG in the scored face).

Trial Locations (1)

500 013

GSK Investigational Site, Hyderabad